Regulation of protein synthesis and autophagy in activated dendritic cells: implications for antigen processing and presentation

Immunological Reviews

Volumn 272, Issue 1, 2016, Pages 28-38

  Argüello, Rafael J ^a   Reverendo, Marisa ^a   Gatti, Evelina ^a,b   Pierre, Philippe ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

antigenic peptide; autophagy; DALIS; DRiPs; peptidome; ribosome

Indexed keywords

ANTIGEN; PROTEASOME; PROTEIN;

AGGRESOME; AGGRESOME LIKE INDUCED STRUCTURE; ANTIGEN PRESENTATION; AUTOPHAGY; CELL ACTIVATION; CELL FUNCTION; DENDRITIC CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN SYNTHESIS REGULATION; REVIEW;

EID: 84975518865     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12427     Document Type: Review

References (63)

1. Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol 2013;31:443–473.
2. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005;23:975–1028.
3. Buchholz VR, Schumacher TN, Busch DH. T cell fate at the single-cell level. Annu Rev Immunol 2016; 34:65–92.
4. Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol 2012;12:557–569.
5. Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012;12:265–277.
6. Vu Manh TP, et al. Defining mononuclear phagocyte subset homology across several distant warm-blooded vertebrates through comparative transcriptomics. Front Immunol 2015;6:299.
7. Alloatti A, et al. Toll-like receptor 4 engagement on dendritic cells restrains phago-lysosome fusion and promotes cross-presentation of antigens. Immunity 2015;43:1087–1100.
8. Starck SR, et al. Translation from the 5′ untranslated region shapes the integrated stress response. Science 2016;351:aad3867.
9. Dolan BP, Bennink JR, Yewdell JW. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands. Cell Mol Life Sci 2011;68:1481–1489.
10. Rock KL, Farfan-Arribas DJ, Colbert JD, Goldberg AL. Re-examining class-I presentation and the DRiP hypothesis. Trends Immunol 2014;35:144–152.
11. Apcher S, Manoury B, Fahraeus R. The role of mRNA translation in direct MHC class I antigen presentation. Curr Opin Immunol 2012;24:71–76.
12. Pierre P. Dendritic cells, DRiPs, and DALIS in the control of antigen processing. Immunol Rev 2005;207:184–190.
13. Starck SR, Shastri N. Non-conventional sources of peptides presented by MHC class I. Cell Mol Life Sci 2011;68:1471–1479.
14. Apcher S, et al. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc Natl Acad Sci USA 2011;108:11572–11577.
15. Apcher S, Millot G, Daskalogianni C, Scherl A, Manoury B, Fahraeus R. Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway. Proc Natl Acad Sci USA 2013;110:17951–17956.
16. David A, et al. Nuclear translation visualized by ribosome-bound nascent chain puromycylation. J Cell Biol 2012;197:45–57.
17. Bourdetsky D, Schmelzer CE, Admon A. The nature and extent of contributions by defective ribosome products to the HLA peptidome. Proc Natl Acad Sci USA 2014;111:E1591–E1599.
18. Starck SR, et al. Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science 2012;336:1719–1723.
19. Anton LC, Yewdell JW. Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors. J Leukoc Biol 2014;95:551–562.
20. Yewdell JW, Anton LC, Bennink JR. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J Immunol 1996;157:1823–1826.
21. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996;4:565–571.
22. + T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo. J Virol 2012;86:9782–9793.
23. Yin Y, Manoury B, Fahraeus R. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 2003;301:1371–1374.
24. de Klerk E, et al. Assessing the translational landscape of myogenic differentiation by ribosome profiling. Nucleic Acids Res 2015;43:4408–4428.
25. Trcek T, Sato H, Singer RH, Maquat LE. Temporal and spatial characterization of nonsense-mediated mRNA decay. Genes Dev 2013;27:541–551.
26. Baboo S, et al. Most human proteins made in both nucleus and cytoplasm turn over within minutes. PLoS ONE 2014;9:e99346.
27. de Turris V, Nicholson P, Orozco RZ, Singer RH, Muhlemann O. Cotranscriptional effect of a premature termination codon revealed by live-cell imaging. RNA 2011;17:2094–2107.
28. Rugjee KN, et al. Fluorescent protein tagging confirms the presence of ribosomal proteins at Drosophila polytene chromosomes. PeerJ 2013;1:e15.
29. Nathanson L, Deutscher MP. Active aminoacyl-tRNA synthetases are present in nuclei as a high molecular weight multienzyme complex. J Biol Chem 2000;275:31559–31562.
30. Malhotra D, et al. Tolerance is established in polyclonal CD4(+) T cells by distinct mechanisms, according to self-peptide expression patterns. Nat Immunol 2016;17:187–195.
31. Ceppi M, et al. Ribosomal protein mRNAs are translationally-regulated during human dendritic cells activation by LPS. Immun Res 2009;5:5.
32. Amit I, et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 2009;326:257–263.
33. Taylor MW, et al. Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro. J Interferon Cytokine Res 2004;24:107–118.
34. Taylor MW, et al. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J Virol 2007;81:3391–3401.
35. Lelouard H, et al. Regulation of translation is required for dendritic cell function and survival during activation. J Cell Biol 2007;179:1427–1439.
36. Lelouard H, et al. Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J Cell Biol 2004;164:667–675.
37. Lelouard H, Gatti E, Cappello F, Gresser O, Camosseto V, Pierre P. Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature 2002;417:177–182.
38. Tyedmers J, Mogk A, Bukau B. Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 2010;11:777–788.
39. Chen B, Retzlaff M, Roos T, Frydman J. Cellular strategies of protein quality control. Cold Spring Harb Perspect Biol 2011;3:a004374.
40. Kaganovich D, Kopito R, Frydman J. Misfolded proteins partition between two distinct quality control compartments. Nature 2008;454:1088–1095.
41. Canadien V, Tan T, Zilber R, Szeto J, Perrin AJ, Brumell JH. Cutting edge: microbial products elicit formation of dendritic cell aggresome-like induced structures in macrophages. J Immunol 2005;174:2471–2475.
42. DeFillipo AM, Dai J, Li Z. Heat shock-induced dendritic cell maturation is coupled by transient aggregation of ubiquitinated proteins independently of heat shock factor 1 or inducible heat shock protein 70. Mol Immunol 2004;41:785–792.
43. Szeto J, et al. ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy. Autophagy 2006;2:189–199.
44. Herter S, et al. Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells. J Immunol 2005;175:891–898.
45. Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013;13:722–737.
46. Hamasaki M, Shibutani ST, Yoshimori T. Up-to-date membrane biogenesis in the autophagosome formation. Curr Opin Cell Biol 2013;25:455–460.
47. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011;13:132–141.
48. English L, et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009;10:480–487.
49. Schmid D, Pypaert M, Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007;26:79–92.
50. Dengjel J, et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci USA 2005;102:7922–7927.
51. Lee HK, et al. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010;32:227–239.
52. Terawaki S, et al. RUN and FYVE domain-containing protein 4 enhances autophagy and lysosome tethering in response to Interleukin-4. J Cell Biol 2015;210:1133–1152.
53. Wenger T, et al. Autophagy inhibition promotes defective neosynthesized proteins storage in ALIS, and induces redirection toward proteasome processing and MHCI-restricted presentation. Autophagy 2012;8:350–363.
54. Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell 2009;34:259–269.
55. Kettern N, Rogon C, Limmer A, Schild H, Hohfeld J. The Hsc/Hsp70 co-chaperone network controls antigen aggregation and presentation during maturation of professional antigen presenting cells. PLoS ONE 2011;6:e16398.
56. Clausen TH, et al. p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy. Autophagy 2010;6:330–344.
57. Demand J, Alberti S, Patterson C, Hohfeld J. Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling. Curr Biol 2001;11:1569–1577.
58. Younger JM, et al. A foldable CFTR{Delta}F508 biogenic intermediate accumulates upon inhibition of the Hsc70-CHIP E3 ubiquitin ligase. J Cell Biol 2004;167:1075–1085.
59. Minami R, Hayakawa A, Kagawa H, Yanagi Y, Yokosawa H, Kawahara H. BAG-6 is essential for selective elimination of defective proteasomal substrates. J Cell Biol 2010;190:637–650.
60. Bitzer A, Basler M, Groettrup M. Chaperone BAG6 is dispensable for MHC class I antigen processing and presentation. Mol Immunol 2016;69:99–105.
61. Arndt V, et al. Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol 2010;20:143–148.
62. Gamerdinger M, Hajieva P, Kaya AM, Wolfrum U, Hartl FU, Behl C. Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J 2009;28:889-901.
63. Munz C, Of LAP. CUPS, and DRibbles – unconventional use of autophagy proteins for MHC restricted antigen presentation. Front Immunol 2015;6:200.